XORTX Therapeutics Inc (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
1.37
0.12 (9.60%)
At close: May 26, 2022 3:59 PM
1.34
-0.03 (-2.19%)
After-hours:May 26, 2022 4:00 PM EDT
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Cash & Equivalents | 18.85 | 0.17 | 0.78 |
| Cash & Cash Equivalents | 18.85 | 0.17 | 0.78 |
| Cash Growth | 10906.68% | -78.18% | - |
| Receivables | 0.05 | 0.01 | 0.02 |
| Other Current Assets | 1.27 | 1.87 | 0.01 |
| Total Current Assets | 20.17 | 2.06 | 0.82 |
| Property, Plant & Equipment | 0 | 0 | 0 |
| Goodwill and Intangibles | 0.26 | 0.23 | 0.27 |
| Other Long-Term Assets | 1.61 | 0 | 0 |
| Total Long-Term Assets | 1.86 | 0.23 | 0.27 |
| Total Assets | 22.04 | 2.29 | 1.09 |
| Accounts Payable | 0.7 | 1.03 | 1.15 |
| Current Debt | 0 | 0 | 0.05 |
| Other Current Liabilities | 4.6 | 0 | 0.1 |
| Total Current Liabilities | 5.3 | 1.03 | 1.3 |
| Total Liabilities | 5.3 | 1.03 | 1.3 |
| Total Debt | 0 | 0 | 0.05 |
| Common Stock | 26.43 | 9.29 | 6.55 |
| Retained Earnings | -9.69 | -8.04 | -6.76 |
| Shareholders' Equity | 16.74 | 1.26 | -0.21 |
| Total Liabilities and Equity | 22.04 | 2.29 | 1.09 |
| Net Cash / Debt | 18.85 | 0.17 | 0.73 |
| Net Cash / Debt Growth | 10906.68% | -76.67% | - |
| Net Cash Per Share | 1.91 | 0.03 | 0.14 |
| Working Capital | 14.88 | 1.02 | -0.48 |
| Book Value Per Share | 1.70 | 0.19 | -0.04 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).